中大職務
婦產科學系系主任
專業範疇
- 臨床母胎醫學：
- 採用最先進的技術進行產前篩查、診斷和諮詢，包括先進的超聲檢查、使用母體循環游離胎兒 DNA (cfDNA) 進行的無創產前檢測，以及下一代測序，例如全外顯子組測序
- 胎兒治療包括胎兒鏡激光治療雙胎輸血綜合症、臍血管射頻消融以選擇性殺胎或減胎、宮內輸血和分流
- 處理複雜的高危產科病例，從雙胞胎的併發症、胎兒宮內發展遲緩，到妊娠期急性脂肪肝、圍產期心肌病
教育及資歷
MBBS (University of London), MRCOG, Cert RCOG (Maternal and Fetal Medicine), MD(Res) (University of London), MSc (Medical Genetics), FHKCOG, FHKAM (Obstetrics and Gynaecology)
專注研究
- 大規模多中心觀察研究和隨機對照試驗
- 先兆子癇(妊娠毒血症)的早期預測和預防
- 孕產婦和圍產期發病率和死亡率的預測和預防
- 預測/檢測染色體異常、胎兒生長受限、妊娠糖尿病、巨大兒、死產和自發性早產
- 分娩和分娩中的超聲波
- 母體心臟功能
- 產前診斷和篩查
- 多胎妊娠
更多資訊
獎項及榮譽
- 英國倫敦國王學院婦女和兒童健康系客座教授
- 希臘母胎醫學協會榮譽會員
專業服務
- 國際婦產科聯盟(FIGO) 妊娠對長期健康影響委員會成員
- 香港婦產科學院孕期接種COVID-19疫苗專家小組委員會主席
- 國際“孕產婦、圍孕期和圍新生兒醫學”基金會創會董事成員
- 歐洲肝臟研究及肝臟疾病和妊娠臨床實踐指引協會委員
- 中國母胎醫學研究院副院長
- 國際婦產科超聲學會 (ISUOG) 受託人和董事會成員
- 母胎醫學期刊Maternal-Fetal Medicine副主編
- 婦產科超聲期刊Ultrasound in Obstetrics and Gynecology編輯
中大教學職務
- 香港中文大學婦女及家庭友善政策專責小組顧問
部分論文 (只有英文版本)
Researcher ID: P-9311-2017
- Chaiyasit N, Sahota DS, Ma R, Choolani M, Wataganara T, Sim WS, Chaemsaithong P, Wah YMI, Hui SYA, Poon LC. Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11-13 Weeks' Gestation. Hypertension 2022; 79:314-322.
- Li X, Milosavljevic A, Elsea SH, Wang CC, Scaglia F, Syngelaki A, Nicolaides KH, Poon LC. Effective Aspirin Treatment of Women at Risk for Preeclampsia Delays the Metabolic Clock of Gestation. Hypertension 2021; 78:1398-1410.
- Yan J, Guo J, Fan C, Juan J, Yu X, Li J, Feng L, Li C, Chen H, Qiao Y, Lei D, Wang C, Xiong G, Xiao F, He W, Pang Q, Hu X, Wang S, Chen D, Zhang Y, Poon LC, Yang H. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases. Am J Obstet Gynecol 2020:S0002-9378(20)30462-2.
- Chaemsaithong P, Sahota D, Pooh RK, Zheng M, Ma R, Chaiyasit N, Koide K, Shaw SW, Seshadri S, Choolani M, Panchalee T, Yapan P, Sim WS, Sekizawa A, Hu Y, Shiozaki A, Saito S, Leung TY, Poon LC. First-trimester pre-eclampsia biomarker profiles in Asian population: a multicenter cohort study. Ultrasound Obstet Gynecol. 2020;56:206-214.
- Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, Shaw SW, Seshadri S, Choolani M, Wataganara T, Yeo GSH, Wright A, Leung WC, Sekizawa A, Hu Y, Naruse K, Saito S, Sahota D, Leung TY, Poon LC. Prospective evaluation of screening performance of first trimester prediction models for preterm preeclampsia in Asian population. Am J Obstet Gynecol. 2019 Dec;221(6):650.e1-650.e16.
- Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nicolaides KH. ASPRE trial: incidence of preterm preeclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm. Ultrasound Obstet Gynecol 2018;51:738-742.
- Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH. ASPRE trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Am J Obstet Gynecol. 2017;217:585.e1-585.e5.
- Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tennebaum Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk of Preterm Preeclampsia. N Engl J Med 2017;377:613-622.
- O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Am J Obstet Gynecol 2016; 214:103.e1-103.e12.
- Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.